Professional Documents
Culture Documents
Hemorragia Uterina Anormal
Hemorragia Uterina Anormal
5mm.6 REFERENCIAS BIBLIOGRAFICAS |. Williams Gynecology, The McGraw-Hill Interamericana editores. México, 2014 7 The Society of Obstetricians and gynaecologist of Canada. SOGC. Abnormal uterine bleeding in pre menopausal women, 2013;35(5 eSuppl):S1-S28 3. Yael Levy-Zauberman, Anne-Gaelle Pourcelot, Pertine Capmas, Herv'e Fernandez. Update on the management of abnormal uterine bleeding (2017), http:/idx.doi.org/10.1016/, jogoh.2017.07.005. 4. Gula de Practica Clinica: Diagnéstico y tratamiento del ‘sangrado uterine anorfnal de corigen no anatomico, México. Secretaria de salud, 2015, He 5. Diagnosis of Abnormal Uterine Bleeding in Reproductive-Aged women, ACOG Practice Bulletin Vol. 120, No, 1, July 2012 . Hallberg L, Hogdahl A-M, Nisson L, Rybo G. Menstrual blood loss—a population study, Acta Obstet Gynecol Scand 1966;45:320-51. Munro MR. FIGO Working Group on Menstrual Disorders. FIGO classcation system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of Teproductive age. Int Gynaecol Obstet 2011;113:3-13. ACOG Committee Opinion Transvaginal Utrasonography No 400 - August 20089. } De Kroom CD. Sale contrast hysterosonography in abnormal uterine bleeding: @ systematic review and metanalysis. Br J Obstet Gynecol. 2003; 110:938.47, . Ciarck TJ . Accuracy ofthe hysteroscopy in the diagnosis of endometrial cancer end hyperplasia. A systematic review. JAMA, 2002; 282'1610-21 - Dusholm’M etal. Magnetic resonance imaging and transvaginal ulrasonography for the diagnosis of adenomyosis, Fertl Steril 2001; 76: 588e503. a f Heavy menstrual bleediny. Unied Kingdom, National Institute for Health dha Clinical Excellence; 2007. 418, Gabriela Baiocchi, MD Malignancy in endometrial polyps: a 12-year experience Am J Obstet Gynecol 2009:201:462.e1-4. 414. Kurman Ru, Kaminski PF. The behaviour of endometrial hyperplasiaza long-term study of "untreated" hyperplasia in 170 patients Cancer 1985; 56: 403e12. 18, Gallos 1D.0rel progestogens vs levonorgestreleleasing intrauterine system for endometrial hyperplasiaa systematic review and meleanalysis.Am J Obstet Gynecel 2010;208:547-e1-10 3 16, Gallos 1D. .LNG-IUS (Mirenaw) versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort study Hum. Reprod. Advance Access published August 23, 2013, 17. Speroff L, Fritz MA, Dysfunctional uterine bleeding. in: Speroff L, Fritz MA, editors. Clinical Gynecologic Endocrinology & Infertility, 7th edPhilzdelphia: Lippincott Wiliams & Wiking; 2005, pp 847-570. } 18, DeVore GR. Use of intravenous Premarin in the treatment of dysfunctional uterine bieeding—a double-bind randomized control study. Obstet Gynecol VolS9:pag 285- 9.1982. 18. Munro MG, Mainor N, Basu R, Bringer M, Barreda L. Oral medroxyprogesterone +s aeetate and combination oral contraceptives for acute uterine bleeding: a randomized __ controlled tral. Obstet Gynecol 2006;108:924-9, “5°20, Management of Acute Abnormal Ute ing-in- Nonpregnait Reproductive ‘Aged Women, Commitice on Gynecologic Practice. Obst & Gyn VOL. 121, No. 4, Apri 2013. 1821. Lethaby A, Farquhar C, Cooke | Antifbrinolyties for heavy menstrual bleeding (Cochrane Review). In: The Cochrane Library, Issue 2. 2004. Chichester, UK: ohn Wiley & Sons, Ltd. 22, Lukes et al Oral Tranexemic Acid for Heavy Menstrual Bleeding. Obstetrcs® Gynecology, Vol. 116, NO. 4, October 2010. 23, Lethaby ANonsteroidal antiinflammatory drugs for heavy menstrual bleeding Cochrane Database Syst Rev.2013;1:CDQ00400, 24, Fuente:OE| INMP 2018